AVIR: the cash flow

MyFinsight

For the year ending 2025-12-31, AVIR had $31,017K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Total research and development expense	137,578
Total general and administrative	22,589
Stock based compensation	20,720
Other segment items	-22,538
Net loss	-158,349
Stock-based compensation expense	20,720
Depreciation and amortization expense	416
Accretion of premium and discounts on marketable securities	4,944
Income tax benefit	-6,356
Prepaid expenses and other current assets	1,527
Other assets	2,939
Accounts payable	8,487
Accrued expenses and other liabilities	12,651
Operating lease liabilities	-190
Net cash used in operating activities	-132,031
Purchases of marketable securities	281,939
Sales and maturities of marketable securities	470,732
Net cash provided by investing activities	188,793
Proceeds from issuance of common stock under espp	201
Proceeds from issuance of common stock upon option exercise	58
Stock repurchase	25,519
Cash paid for taxes in connection with rsu and psu vesting	485
Net cash (used in) provided by financing activities	-25,745
Net increase (decrease) in cash and cash equivalents	31,017
Cash and cash equivalents at the beginning of period	64,696
Total cash and cash equivalents	95,713

Unit: Thousand (K) dollars (except for numbers of shares and EPS).